Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/16/24 08:00 | 1/12/24 | ENTX | Health | BioPrd | Biological Products, (No Diag | Taitel Haya | L3 | D | 3 | P | 26 | 0.7542 | 0 | 35 | 35 | D | ||||||||||||||||
12/27/23 17:00 | 12/22/23 | ENTX | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | 2 | P.d | 29 | 0.6550 | 0 | 44 | 21 | 252 | D | |||||||||||||||
12/27/23 08:27 | 12/22/23 | ENTX | Health | BioPrd | Biological Products, (No Diag | Toledano Miranda Jayne | L3 | DO | CEO | 2 | P.d | 47 | 0.8768 | 0 | 54 | 95 | 111 | D | ||||||||||||||
8/22/23 09:20 | 8/21/23 | ENTX | Health | BioPrd | Biological Products, (No Diag | Ellis Sean | L3 | D | 1 | P | 24 | 0.6000 | 0 | 40 | 64 | 102 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |